Introduction
With its helix-loop-helix DNA-binding domain, Foxo3 is involved in an abundance of cellular processes such as cell cycle regulation, apoptosis, oxidative stress, angiogenesis, and immunity. 1 The activation of Foxo3 is regulated via differential phosphorylation. Growth factors lead to phosphorylation of Foxo3 via the PI3K/ Akt pathway inducing its cytoplasmic sequestration and degradation. Oxidative stress or glucose phosphorylate Foxo3 via the AMPK pathway on specific consensus sites leading to its activation and differential target gene expression. 1 Moreover, sirtuins have been implicated in Foxo3 transcription. 2 Although Foxo proteins are expressed by immune cells, their physiological role in immune responses during an infection is still not fully understood. Single nucleotide polymorphisms (SNPs) in the FOXO3 gene are associated with longevity, a better self-rated health, and low prevalence of cardiovascular diseases in independent populations. 1 Importantly, a human SNP in FOXO3 was recently shown to be associated with an increased risk for malaria but with a milder course in patients with autoimmune disease. 3 The immune-modulatory function of Foxo3 in adaptive immune responses has been elucidated to some extent. Foxo3 contributes to the maintenance of T cell tolerance and quiescence as deficiency leads to a mild, spontaneous helper T-cell related lymphoproliferation. 4 Together Foxo3 and Foxo1 control the differentiation of regulatory T cells via the protein kinase C/Akt pathway and TGF-b. 5 Foxo3 non-redundantly suppresses cytokine production by dendritic cells (DCs) and limits sequelae of viral infections. 6 Moreover, Foxo3 has been shown to maintain neutrophil vitality by suppressing Fas ligand in models of neutrophil inflammation. 7 Foxo3 induces apoptosis in primed CD8 þ T cells via pro-apoptotic Bim transcription during infection 8 but acts anti-apoptotic on T cells of synovial aggregates in rheumatoid arthritis 9 and memory T and B cells in HIV infection. [10] [11] [12] We and others have previously shown that Foxo3 plays an important role in cardiac hypertrophy, 13, 14 cardiomyocyte survival, cell differentiation, and remodelling. [15] [16] [17] Furthermore, Foxo3 provokes resistance to oxidative stress in cardiac fibroblasts 18 as well as anti-inflammatory effects via inhibition of nuclear factor kappa B (NFjB). 4 Viral infection-triggered myocarditis is associated with a high mortality and one of the causes for the need for heart transplantation. 19 Nevertheless, it is not well understood how the immune system recognizes and controls coxsackie virus B3 (CVB3) infections. Studies in mice suggest that natural killer (NK) cells play a critical role in viral clearance and host survival. 20 In the acute phase of CVB3 myocarditis (Day 3 p.i.), the innate immune response characterized by accumulation of interferons and NK cells is activated. In subacute CVB3 myocarditis (Day 7 p.i.), intra-cardiac replication of CVB3 activates the adaptive immune response characterized by cellular immune infiltrates (i.e. T cells and macrophages). 21 In the present study, we analyse the effects of Foxo3 on NK cell function during murine CVB3 infection and describe an association of FOXO3 SNP rs12212067 with human NK cell function as well as outcome in virus-positive inflammatory cardiomyopathy (viral CMI).
Methods
Mice and in vivo coxsackie virus B3 myocarditis model Splenocytes, hearts, and blood of FVB/N Foxo3 À/À (kindly provided by RA DePinho, Dana-Farber, Boston, MA, USA) and FVB/N wild-type (WT) littermates were used for the experiments that were conform to the NIH Guide for the Care and Use of Laboratory Animals (NHI Pub. No. 85-23, Revised 1996) and were approved by the regional authorities for provisions on labour, health, and technical safety, Berlin, Germany. Coxsackie virus B3 infection, assessment of disease severity score, and viral load are described in the Supplementary material online in detail.
Cell culture and reagents
Recombinant murine IL-2 (Sigma) was used at 50 or 200 U/mL for NK cell stimulation. Isolation and viral transduction of embryonic mouse cardiomyocytes and HeLa cells as well as assessment of viral titres and copy number are described in the Supplementary material online in detail.
Real-time PCR (RT-PCR)/protein analysis
Total RNA extracted from murine hearts was reverse transcribed and TaqMan V R analyses were performed as described in the Supplementary material online. Western blotting employing polyclonal VP1 antiserum and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) specific antibodies was performed as described in Supplementary material online.
Single nucleotide polymorphisms analysis
Analysis of the FOXO3 SNP rs12212067 was performed according to manufacturer's instruction (Applied Biosystems).
Flow cytometry analysis
Cells were stained extracellularly for immune markers and intracellularly for interferon-c (IFNc) according to Supplementary material online.
Nature killer cell cytotoxicity assay
Cytotoxicity of murine NK cells was measured by the in vitro killing assay LIVE/DEAD Cell Mediated Cytotoxicity Kit (Invitrogen) following the manufacturer's instructions. Detailed information is given in the Supplementary material online.
Locked nucleic acid transfection
Murine splenocytes were transfected with locked nucleic acid (LNA)-scrambled and LNA-miR-155 (Exiqon) with Neon Transfection System as described in the Supplementary material online.
Patient data, blood, and human cardiac biopsy samples
Data of viral CMI patients were retrospectively generated from a data bank of the collaborative research network SFB19. Cardiac biopsies and blood were taken from patients and blood from healthy controls, respectively. Detailed information is given in the Supplementary material online. The study was approved by the Institutional Ethics Committee (Charité Berlin). Informed consent was obtained from all subjects.
Statistical analysis
Descriptives include absolute and relative frequencies for categorical variables. Quantitative measurements were expressed as mean and standard deviation or as Boxplots, showing median, quartiles, and Whiskers 
(Tukey). Comparisons between two independent groups were done using two-or hypothesis-driven one-tailed test. Since for all statistical between group comparisons at least in one of the groups distribution was skewed non-parametric Mann-Whitney U test was used with a P-value 0.05 considered as statistically significant. No Bonferroni correction has been performed. Statistical analyses were done using the software SPSS Statistics 22.
Results

Foxo3 deficiency protects from coxsackie virus B3 myocarditis
To gain mechanistic insights into the role of Foxo3 in viral cardiomyopathy, a model of CVB3 induced acute and subacute myocarditis that mimics certain aspects of human disease was comparatively assessed in FVB/N WT mice and Foxo3 À/À littermates.
Characterization of splenic and bone marrow immune cell composition at baseline in WT and Foxo3 À/À mice was done by flow cytometry. As shown in Supplementary material online, Figure S1A ,B Figure 1A ). However, Foxo3 À/À mice showed significantly enhanced expression of IFNc, indicating NK cell activation, in early viral infection ( Figure 1A) , when compared to WT littermates. In accordance, expression of NKp46-an activating receptor belonging to the family of natural cytotoxicity receptors constitutively expressed on NK cells 22 -was significantly up-regulated in cardiac tissue of Foxo3 À/À animals ( Figure 1B) .
Interestingly, cardiac expression of CD14 expressed on macrophages and monocytes, although up-regulated in acute CVB3 myocarditis, was not differentially expressed in both groups of mice ( Figure 1B) . Moreover, T cell marker CD3 was not differentially regulated. These data indicate an enhanced cardiac viral NK cell response in Foxo3
Subacute CVB3 myocarditis (Day 7 p.i.) characterized by viral replication was characterized by pronounced cardiac inflammation depicted by inflammatory infiltrates in WT mice ( Figure 1C,D) . The inflammatory score assessed by HE-staining, however, was significantly reduced in hearts of Foxo3 À/À mice ( Figure 1C,D Figure 1E ). Viral infection up-regulated mRNA expression of pro-inflammatory cytokines TNFa, IFNb, and IFNc in WT animals, which were significantly diminished in hearts of Foxo3 À/À mice while no difference was observed for IL-1b ( Figure 1F ).
Abundant inflammation and ongoing viral replication have been shown to trigger myocardial injury in CVB3 myocarditis. 23 Wild-type mice exhibited myocardial necrosis located primarily around inflammatory infiltrates ( Figure 1G,H Table S1 ). However, differences in LVESD were not detectable on Day 7 p.i. in subacute myocarditis due to increase in those measurements in the WT group paralleling increased inflammation and tissue injury in WT littermates. Interestingly, resolving inflammation (see Supplementary material online, Figure S2 ) at Day 35 p.i. 24, 25 was associated with changes in echocardiographic measurements to baseline (see Supplementary material online, Table S1 ). However, probably as a marker for unfavourable remodelling, stroke volume in WT mice was significantly diminished at this time-point (see Supplementary material online, Table S1 ) paralleling increased fibrosis in WT animals (see Supplementary material online, Figure S2 ). Taken together, our data implicate that enhanced innate immunity and attenuated cardiac inflammation on Day 7 p.i. are associated with reduced myocardial tissue injury in Foxo3 À/À mice.
Foxo3 deficiency is associated with lower cardiac viral titres in coxsackie virus B3 myocarditis (H) Representative cardiac H&E staining is depicted (*P 0.05, **P 0.01, ***P 0.001 and n.s., not significant; n.d., not detected). Figure 4A ). In accordance with these data, IL-2 stimulated Foxo3 À/À NK cells isolated from animals post CVB3 infection possessed a significantly higher cytotoxic capacity compared to stimulated NK cells of infected WT mice ( Figure 4A ). As shown in Figure 4B , Foxo3 deficiency was not associated with enhanced apoptosis under baseline conditions. However, following CVB3 infection, a significant higher percentage of NK cells underwent apoptosis in Foxo3 deficient animals, an observation that is in accordance with higher NK cell activation and cytotoxic activity. Additionally, significant higher frequencies of cytokine-producing effector CD11b þ CD27 þ NKp46 þ NK cells 28 from Foxo3 À/À mice were determined ( Figure 4C) . À/À mice ( Figure 4E) . However, overall expression levels of miR-155 in mice hearts where increased after CVB3 infection but not differentially regulated in both groups of mice ( Figure 4E ). As shown in Figure 4F , inhibition of miR-155 expression employing a specific LNA against miR-155 significantly diminished IFNc expression in NK cells following 24 h of IL-2 stimulation compared to treatment with scrambled LNA (control). Taken together, enhanced functional capacity of Foxo3 À/À mice was dependent on mir-155 expression.
Evidence for human FOXO3 polymorphisms regulating natural killer cell function
Recently, an association of FOXO3 SNP rs12212067 leading to enhanced FOXO3 transcription with less severe inflammatory disease has been described. 3 Human NK cells can be classified in two distinct subsets by the expression of the cell adhesion molecule CD56. CD56 bright NK cells produce abundant cytokines following activation and are mostly found in lymphoid organs while CD56 dim NK cells are defined by their cytotoxic response and predominantly found in peripheral blood. 30 We thus studied the association of NK cell function with this SNP in healthy humans. Donors carrying the minor (G/G) and heterozygous (G/T) alleles (SNP carriers) showed significantly attenuated IFNc expression of NK cells activated by Toll-like Receptor-7/8 ligand R848, a potent stimulator for IFNc production in NK cells ( Figure 5A) . We further observed diminished frequencies of Figure 5B) . Taken together, our data suggest that donors carrying the FOXO3 SNP rs12212067 exhibit attenuated NK cell functions, i.e. decreased IFNc expression further supporting an immune-inhibitory function resulting from enhanced FOXO3 activation in human subjects corroborating data in loss of Foxo3 function mice characterized by increased NK cell activity.
FOXO3 SNP rs12212067 and outcome in human inflammatory cardiomyopathy (CMI)
FOXO3 SNP rs12212067 prevalence was determined in patients with viral CMI (n = 114) and healthy controls (n = 77) ( Table 1 ).
In accordance with earlier studies, 3 no significant difference in the frequencies of the FOXO3 SNP was determined in patients ( Figure 5C ,D) indicating that FOXO3 activity is not involved in susceptibility to viral infection. However, SNP carriers showed a more severe disease characterized by numerically lower left-ventricular ejection fraction (LVEF) at first presentation as well as attenuated improvement of cardiac function at follow-up (LVEF 46.5 ± 14.7% vs. 60.5 ± 13.4%, P < 0.0092) ( Tables 2 and 3) . Accordingly, the decrease in left ventricular end-diastolic diameter (LVEDD) during this period was significantly attenuated in SNP carriers compared to non-SNP carriers (0 ± 5.0 mm vs. -3 ± 7.7 mm, P < 0.04). Moreover, SNP carriers exhibited decreased viral elimination (16% vs. 33% no SNP carriers) ( Figure  5E,F) . Accordingly, SNP carriers showed enhanced inflammation determined by immunohistochemically proven cardiac perforin þ cell infiltration (P < 0.004) and increased human leukozyte antigen (HLA-1) expression (area fraction P < 0.0008) at baseline. At follow-up, SNP rs12212067 carriers were still characterized by significantly enhanced Mac-1 positive infiltrates within the heart (P < 0.01) ( Tables 2 and 3) . Taken together, in contrast to Foxo3 À/À mice viral CMI patients carrying the gain-of-function FOXO3 SNP rs12212067 show enhanced inflammation and decreased viral clearance associated with attenuated improvement of cardiac functional parameters suggesting a more severe course of the disease ( Figure 6 ).
Discussion
In the present study, we show that deficiency of Foxo3 results in ameliorated murine viral myocarditis assessed by enhanced cytotoxic NK cell activity, reduced viral titres, fewer cardiac inflammatory infiltrates, and attenuated tissue injury. For the first time, we describe an association of the gain-of-function FOXO3 SNP rs12212067 and outcome in human viral CMI. This might be very interesting with regard to recent data about discordant effects of increased FOXO3 activation in chronic autoimmune vs. pathogen-induced inflammation. 31 Healthy human carriers of the variant rs12212067 show diminished NK cell activation. In line with this, a poorer outcome associated with less efficient viral clearance and enhanced cardiac inflammation in patients with viral CMI bearing the gain-of-function allele was determined manifesting with depressed left ventricular ejection fraction. Viral myocarditis is characterized by inflammation, cardiomyocyte destruction, reparative fibrosis and heart failure. In most patients, the innate immune response leads to elimination of virus followed by Foxo3 regulates NK cells function termination of the inflammatory response. Diminished early clearance of virus causes direct viral injury triggering an inflammatory process that sometimes outlasts the initial replicative phase and may lead to post-viral autoimmunity. Therefore, it is important to decipher the mechanisms of control of CVB3 as well as interactions with cells of the host's immune system. Natural killer cells are key players in innate immunity and the early host response to viral infection. Furthermore, NK cells secrete pro-inflammatory cytokines for the initiation of an efficient adaptive antiviral immune response. Our in vivo data derived from a mouse model of viral myocarditis clearly show that NK cells convey enhanced antiviral activity during the acute phase of CVB3 infection when the transcription factor Foxo3 is absent. Enhanced cardiac NK cell accumulation, NK cell killing and IFNc synthesis were observed in the acute phase of CVB3 myocarditis in Foxo3 À/À mice. Of note, we observed reduced NK cell mediated killing after CVB3 infection in both groups of mice. In patients with acute hepatitis infection reduced NK cell cytotoxicity and activation is observed as well 32 due to exhaustion of active NK cells. Moreover, we determined enhanced NK cell activation and differentiation in Foxo3 deficiency. Natural killer cells activated by IL-2 acquire enhanced cytotoxic and lytic potential as well as enhanced IFNc secretion and CD69 surface expression. 33 The observed effects might be NK cell intrinsic or mediated by secondary mechanisms due to differential regulation of NK cells when Foxo3 is absent. In this regard, deficiency of Foxo1 and Foxo3 is known to suppress regulatory T cell development. 34 However, recent data showing that knockout of Foxo3 alone seems not sufficient to suppress regulatory T cells argue against this hypothesis. 34 Furthermore, deficiency of Foxo3 results in enhanced T cell expansion after viral infection. This mechanism is not T cell-intrinsic but due to enhanced capacity of Foxo3 deficient DCs to sustain T cell viability. 6 Dejean et al. found enhanced DC activation in Foxo3 À/À mice of C57BL/6 background. In our experiments, mice with a FVB background were used. Therefore, most probably neither regulatory T cell proliferation nor differential DC activation are mechanisms for regulation of NK cell function observed in our study. Our data in subacute CVB3 myocarditis depict reduced viral load and myocardial inflammation at Day 7 in Foxo3 For the first time, we describe an association between carrier status of FOXO3 gain-of-function SNP rs12212067 and outcome in human viral CMI. SNP allele frequencies are not different between patients and controls since they are not assumed to influence infection per se, but instead only the later response of the infected individual to this randomly occurring exogenous virus infection mediated by SNP-dependent differential immune reactivity. Recent studies indicate that presence of cardiac inflammation is linked to outcome in CMI. 41, 42 Our data confirm a recent study in humans showing that SNP rs12212067 is associated with a more deleterious course of pathogen-induced inflammation. 3 Although the number of patients investigated here was small, these patients were well characterized and closely followed. Therefore, our human results must be considered to be hypothesis generating. However, our data is corroborated by our 
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